Pharmacologic management of mesenteric occlusive disease

Cardiology in Review

Volumn 16, Issue 2, 2008, Pages 59-68

  Frishman, William H ^a,d   Novak, Sofia ^b   Brandt, Lawrence J ^b   Spiegel, Adam ^a   Gutwein, Andrew ^a   Kohi, Maureen ^c   Rozenblit, Grigory ^a  

^a WESTCHESTER MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Acute chronic mesenteric ischemia; Colon ischemia; Mesenteric vascular disease; Mesenteric venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; DEXTRAN 40; FLUOROCARBON; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; HEPARIN; IMMUNOSUPPRESSIVE AGENT; PAPAVERINE; PENTOXIFYLLINE; PERHEXILINE MALEATE; PROSTAGLANDIN; PROTEINASE INHIBITOR; SAUVAGINE; SCAVENGER; STEROID; STREPTOKINASE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; UROTENSIN I; WARFARIN; XANTHINE OXIDASE INHIBITOR;

ANGIOGRAPHY; BLOOD CLOT LYSIS; DISEASE COURSE; HUMAN; INCIDENCE; MESENTERIC BLOOD VESSEL OCCLUSION; MORBIDITY; REVIEW; SURVIVAL; VASODILATATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTICOAGULANTS; COLON; EMBOLISM; FREE RADICAL SCAVENGERS; HUMANS; ISCHEMIA; MESENTERIC VASCULAR OCCLUSION; MESENTERY; PROTEASE INHIBITORS; THROMBOLYTIC THERAPY; THROMBOSIS; VASODILATOR AGENTS; VENOUS THROMBOSIS;

EID: 39449115815     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/CRD.0b013e31815a6600     Document Type: Review

References (124)

1. Wilson DB, Mostafavi K, Craven TE, et al. Clinical course of mesenteric artery stenosis in elderly Americans. Arch Intern Med. 2006;166:2095-2100.
2. Char D, Hines G. Chronic mesenteric ischemia. Diagnosis and treatment. Heart Dis. 2001;3:231-235.
3. AGA Technical Review on Intestinal Ischemia (American Gastroenterological Association). Gastroenterology. 2000;118:954-968.
4. Brandt LJ. Ischemic bowel: how often is it misdiagnosed? In: Barkin J, Rogers A, eds. Difficult Decisions in Digestive Diseases. Chicago, IL: Year Book Medical Publishers; 1989:359-361.
5. Abbot WM, Maloney RD, McCabe CC, et al. Arterial embolism: a 44 year perspective. Am J Surg. 1982;143:460-464.
6. Batellier J, Kieny R. Superior mesenteric artery embolism: Eighty-two cases. Ann Vasc Surg. 1990;4:112-116.
7. Freischlag JA, Towne JB: Mesenteric ischemia. In: Haimovici H, Ascer E, Hollier LH, et al., eds. Vascular Surgery. 4th ed. Cambridge, MA: Blackwell Science; 1996:996-1007.
8. Bakal CW, Sprayregen S, Wolf EL. Radiology in intestinal ischemia: angiographic diagnosis and management. Surg Clin North Am. 1992;72:125-141.
9. Brandt LJ. Intestinal ischemia. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 8th ed. Philadelphia, PA: Saunders; 2006:2563-2585.
10. Cohn I, Floyd CE, Dresde F, et al. Strangulation obstruction in germ free animals. Ann Surg. 1962;156:692-702.
11. Plonka AJ, Schentag JJ, Messinger S, et al. Effects of enteral and intravenous antimicrobial treatment on survival following intestinal ischemia in rats. J Surg Res. 1989;46:216-220.
12. Samel S, Keese M, Kleczka M. Microscopy of bacterial translocation during small bowel obstruction and ischemia in vivo - a new animal model. BMC Surgery. 2002;2:6.
13. Panés J, Piqués JM. Intestinal ischemia. In: Yamada T, Alpers DH, Kaplowits N, et al. eds. Textbook of Gastroenterology. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003:2741-2756.
14. Kozuch PL, Brandt LJ. Review article: diagnosis and management of mesenteric ischaemia with an emphasis on pharmacotherapy. Aliment Pharmacol Ther. 2005;21:201-215.
15. Boley SJ, Sprayregen S, Siegelman SS, Veith FJ. Initial results from an aggressive roentgenological and surgical approach to acute mesenteric ischemia. Surgery. 1977;82:848-855.
16. Clark RA, Gallant TE. Acute mesenteric ischemia: angiographic spectrum. Am J Roentgenol. 1984;142:555-562.
17. O'Mara CS, Ernst CB. Acute mesenteric ischemia. In: Zuidema GD, Nyhus LM, eds. Shackelford's Surgery of the Alimentary Tract. 4th ed. Philadelphia, PA: WB Saunders; 1996:17-32.
18. Rivers SP, Veith FJ. Nonocclusive mesenteric ischemia. In: Rutherford RB, ed. Vascular Surgery. 4th ed. Philadelphia, PA: WB Saunders; 1995:1284-1288.
19. Kukovetz WR, Poch G. Inhibition of cyclic 3′,5′ nucleotide-phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs. Naunyn Schmiede Arch Pharmacol. 1970;267:189-194.
20. Hunter GC, Guernsey JM. Mesenteric ischemia. Med Clin North Am. 1988;72:1091-1115.
21. Boley SJ, Feinstein FR, Sammartano R, et al. New concepts in the management of emboli of the superior mesenteric artery. Surg Gynecol Obstet. 1981;153:561-569.
22. Williams RA, Wilson SE. Effect of intraarterial vasodilators on blood flow in ischemic dog colon. Arch Surg. 1980;115:602-605.
23. Kaleya RN, Sammartano RJ, Boley SJ. An aggressive approach to acute mesenteric ischemia. Surg Clin North Am. 1992;72:157-182.
24. McKinsey JF, Gewertz BL. Acute mesenteric ischemia. Surg Clin North Am. 1997;77:307-318.
25. Pai SM, Torres V. Atrial fibrillation: new management strategies. Curr Probl Cardiol. 1993;18:235-300.
26. Hylek EM, Skates SJ, Sheehan MA, et al. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med. 1996;335:540-546.
27. Schoenbaum SW, Pena C, Koenigsberg P, Katzen BT. Superior mesenteric artery embolism: treatment with intraarterial urokinase. J Vasc Intervent Radiol. 1992;3:485-490.
28. Vujic I, Stanley J, Gobien R. Treatment of an acute embolus of the SMA by topical infusion of streptokinase. Cardiovasc Intervent Radiol. 1984;7:94-96.
29. McBride KD, Gaines PA. Thrombolysis of a partially occluding superior mesenteric artery thromboembolism by infusion of streptokinase. Cardiovasc Intervent Radiol. 1994;17:164-166.
30. Regan F, Karlstad RR, Magnuson TH. Minimally invasive management of acute superior mesenteric artery occlusion: combined urokinase and laparoscopic therapy. Am J Gastroenterol. 1996;91:1019-1021.
31. Simo G, Echenagusia AJ, Camunez F, et al. Superior mesenteric embolism: local fibrinolytic treatment with urokinase. Radiology. 1997;204:775-779.
32. Yamaguchi T, Saeki M, Iwasaki Y, et al. Local thrombolytic therapy for superior mesenteric artery embolism: complications and long-term clinical follow up. Rad Med. 1999;17:27-33.
33. Barakate MS, Cappe I, Curtin A, et al. Management of acute superior mesenteric artery occlusion. ANZ J Surg. 2002;V72:25-29.
34. Schoots IG, Levi MM, Reekers JA, et al. Thrombolytic therapy for acute superior mesenteric artery occlusion. J Vasc Interv Radiol. 2005;16:317-329.
35. Gurll N, Zinner MJ, Turtinen L, Reynolds DG. Vasodilation, fibrinolysis, and thrombolysis with intraarterial infusion of urokinase in the canine superior mesenteric artery. Gastroenterology. 1978;75:425-431.
36. Schoots IG, Koffeman GI, Legemate DA, et al. Systemic review of survival after acute mesenteric ischaemia according to disease aetiology. Br J Surg. 2004;91:17-27.
37. Bell WR, Meek AG. Guidelines for the use of thrombolytic agents. N Engl J Med. 1979;301:1266-1270.
38. Acosta S, Ogren M, Sternby NH, et al. Fatal nonocclusive mesenteric ischaemia: population-based incidence and risk factors. J Intern Med. 2006;259:305-313.
39. Kaleya RN, Boley SJ: Acute mesenteric vascular disease. In: Veith FJ, Hobson RW II, Williams RA, et al., eds. Vascular Surgery: Principles and Practice. 2nd ed. New York, NY: McGraw-Hill; 1994:762-780.
40. Wilson C, Gupta R, Gilmour DG, et al. Acute superior mesenteric ischaemia. Br J Surg. 1987;74:279-281.
41. Niederhauser U, Genoni M, von Segesser LK, et al. Mesenteric ischemia after a cardiac operation: conservative treatment with local vasodilation. Ann Thorac Surg. 1996;61:1817-1819.
42. Eker A, Malzac B, Teboul J, Jourdan J. Mesenteric ischemia after coronary artery bypass grafting: should local continuous intra-arterial perfusion with papaverine be regarded as a treatment? Eur J Cardiothorac Surg. 1999;15:218-220.
43. Ori Y, Chagnac A, Schwartz A, et al. Non-occlusive mesenteric ischemia in chronically dialyzed patients: a disease with multiple risk factors. Nephron Clin Pract. 2005;101:c87-c93.
44. Demirpolat G, Oran I, Tamsel S, et al. Acute mesenteric ischemia: endovascular therapy. Abdom Imaging. 2007;32:299-303.
45. Hung KH, Lee CT, Lam KK, et al. Ischemic bowel disease in chronic dialysis patients. Chang Keng I Hsueh Tsa Chih. 1999;22:82-87.
46. Bailey RW, Bulkely GB, Hamilton SR, et al. Protection of the small intestine from nonocclusive mesenteric ischemic injury due to cardiogenic shock. Am J Surg. 1987;153:108-116.
47. Jakschik J, Decker P, Hirner A. [Significance of therapy timing for the effects of systemic and local therapy with the ACE inhibitor captopril on intestinal microcirculation in manifest mesenteric ischemia. An animal experiment study in the swine] Langenbecks Arch Chir. 1995;380:273-280.
48. Takagi TA, Yoshida N, Isozaki Y, et al. CV-11974, angiotensin II type I receptor antagonist, protects against ischemia-reperfusion injury of the small intestine in rats. Euro J Pharmacol. 2006;535:283-290.
49. Ypsilantis DVM, Lambropoulou M, Tentes I, et al. Mesna protects intestinal mucosa from ischemia/reperfusion injury. J Surg Res. 2006;134:278-284.
50. Uchiyama T, Delude RL, Fink MP. Dose-dependent effects of ethyl pyruvate in mice subjected to mesenteric ischemia and reperfusion. Intensive Care Med. 2003;29:2050-2058.
51. Fink MP. Ethyl pyruvate: a novel anti-inflammatory agent. Crit Care Med. 2003;31:S51-S56.
52. Hammerman C, Goldschmidt D, Caplan MS, et al. Protective effect of bilirubin in ischemia-reperfusion injury in the rat intestine. J Pediatr Gastroenterol Nutr. 2002;35:344-349.
53. Tomatsuri N, Yoshida N, Takagi T, et al. Edaravone, a newly developed radical scavenger, protects against ischemia-reperfusion injury of the small intestine in rats. Int J Mol Med. 2004;13:105-109.
54. Ozaemak VH, Sayan H, Arslan SO, et al. Protective effect of melatonin on contractile activity and oxidative injury induced by ischemia and reperfusion of rat ileum. Life Sci. 2005;76:1575-88.
55. Demetriou AA, Kagoma PK, Kaiser S, et al. Effect of dimethyl sulfoxide and glycerol on acute bowel ischemia in the rat. Am J Surg. 1985;149:91-94.
56. Parks DA, Bulkley GB, Granger DN, et al. Ischemic injury in the cat small intestine: role of superoxide radicals. Gastroenterology. 1982;82:9-15.
57. Granger DN, McCord JM, Parks DA, Hollwarth ME. Xanthine oxidase inhibitors attenuate ischemia-induced vascular permeability changes in the cat intestine. Gastroenterology. 1986;90:80-84.
58. Ciz M, Cizova H, Lojek A, et al. Ischemia/reperfusion injury of rat small intestine: the effect of allopurinal dosage. Transplant Proceed. 2001;33:2871-2873.
59. Ilhan H, Alatas O, Tokar B, et al. Effects of the anti-ICAM-1 monoclonal antibody, allopurinol, and methylene blue on intestinal reperfusion injury. J Ped Surg. 2003;38:1591-1595.
60. Kula B, Besler HT, Akdag M, et al. The effects of verapamil vs. allopurinol on intestinal ischemia/reperfusion injury in rats. "An experimental study". Hepatogastroenterology. 2004;51:401-407.
61. La M, Tailor A, D'Amico M, et al. Analysis of the protection afforded by annexin 1 in ischaemia-reperfusion injury: focus on neutrophil recruitment. Eur J Pharmacol. 2001;429:263-278.
62. Vohra K, Rosenfeld W, Singh I, Anderson V. Ischemic injury to newborn rabbit ileum: protective role of human superoxide dismutase. J Ped Surg. 1989;24:893-898.
63. Zimmerman BJ, Granger DN. Reperfusion injury. Surg Clin North Am. 1992;72:65-83.
64. Ulano HB, Treat E, Shanbour LL, Jacobson ED. Selective dilation of the constricted superior mesenteric artery. Gastroenterology. 1972;62:39-47.
65. Davis LJ, Anderson J, Wallace S, Jacobson ED. Experimental use of prostaglandin E1 in non-occlusive mesenteric ischemia. Am J Roentgenol Radium Ther Nucl Med. 1975;125:99-110.
66. Fondacaro JD, Walus KM, Schwaiger M, et al. Vasodilation of the normal and ischemic canine mesenteric circulation. Gastroenterology. 1981;80:1542-1549.
67. Schwaiger M, Fondacaro JD, Jacobson ED. Effects of glucagon, histamine and perhexiline on the ischemic canine mesenteric circulation. Gastroenterology. 1979;77:730-735.
68. Kang H, Manasia A, Rajamani S, et al. Intravenous iloprost increases mesenteric blood flow in experimental acute nonocclusive mesenteric ischemia. Crit Care Med. 2002;30:2528-2534.
69. Lanciault G, Fang WF, Jacobson ED, et al. Evaluation of potential agents for treatment of nonocclusive mesenteric ischemia in the dog. Circulatory Shock. 1976;3:239.
70. Bond JH, Levitt MD. Effect of glucagon on gastrointestinal blood flow of dogs in hypovolemic shock. Am J Physiol. 1980;238:434-439.
71. Gangadharan SP, Wagner RJ, Cronenwett JL. Effect of intravenous glucagon on intestinal viability after segmental mesenteric ischemia. J Vasc Surg. 1995;21:900-909.
72. Levinsky RA, Lewis RM, Bynum TE, Hanley HG. Digoxin induced intestinal vasoconstriction. The effects of proximal arterial stenosis and glucagon administration. Circulation. 1975;52:130-136.
73. Clark ET, Gewertz Bl. Glucagon potentiates intestinal reperfusion injury. J Vasc Surg. 1990;11:270-207.
74. Kogire M, Inoue K, Sumi S, et al. Effects of synthetic human gastric inhibitory polypeptide on splanchnic circulation in dogs. Gastroenterology. 1988;95:1636-1640.
75. MacCannell KL, Newton CA, Lederis K, et al. Use of selective mesenteric vasodilator peptides in experimental nonocclusive mesenteric ischemia in the dog. Gastroenterology. 1986;90:669-676.
76. Bounous G, Hampson LG, Gurd FN. Cellular nucleotides in hemorrhagic shock: relationship of intestinal metabolic changes to hemorrhagic enteritis and the barrier function of intestinal mucosa. Ann Surg. 1964;160:650-666.
77. Bounous G, Brown RA, Mulder DS, et al. Abolition of tryptic enteritis in the shocked dog. Arch Surg. 1965;91:371-375.
78. Fitzal F, DeLano FA, Young C, et al. Pancreatic protease inhibition during shock attenuates cell activation and peripheral inflammation. J Vasc Res. 2002;39:320-329.
79. Bounous G. Pancreatic proteases and oxygen-derived free radicals in acute ischemic enteropathy. Surgery. 1986;99:92-94.
80. Fitzal F, DeLano FA, Young C, et al. Improvement in early symptoms of shock by delayed intestinal protease inhibition. Arch Surg. 2004;139:1008-1016.
81. Oldham KT, Guice KS, Gore D, et al. Treatment of intestinal ischemia with oxygenated intraluminal perfluorocarbons. Am J Surg. 1987;153:291-294.
82. Hameed SM, Aird WC, Cohn SM. Oxygen delivery. Crit Care Med. 2003;31(Suppl):S658-S667.
83. Ricci JL, Sloviter HA, Ziegler MM. Intestinal ischemia: reduction of mortality utilizing intraluminal perfluorochemicals. Am J Surg. 1985;149:84-90.
84. Daniel WJ, Mohamed SD, Matheson NA. Treatment of mesenteric embolism with dextran 40. Lancet. 1966;12:567-569.
85. Boley SJ, Kaleya RN, Brandt LJ. Mesenteric venous thrombosis. Surg Clin North Am. 1992;72:183-201.
86. Kairaluoma MI, Karkola P, Heikkinen E, et al. Mesenteric infarction. Am J Surg. 1977;133:188-193.
87. Moriau M, Zzerad MA. Importance of medical treatment in mesenteric vein thrombosis (MVT). Acta Gastroenterol Belg. 1996;59:146-149.
88. Rhee RY, Gloviczki P, Mendonca CT, et al. Mesenteric venous thrombosis: still a lethal disease in the 1990s. J Vasc Surg. 1994;20:688-697.
89. Elliot JW. The operative relief of gangrene of intestine due to occlusion of the mesenteric vessels. Ann Surg. 1895;21:9-23.
90. Cokkinis AJ. Mesenteric Vascular Occlusion. Balliere: Tindall & Cox; 1926:1-93.
91. Warren S, Eberhard TP. Mesenteric venous thrombosis. Surg Gynecol Obstet. 1935;141:740-742.
92. Kumar S, Sarr MG, Kamath PS. Mesenteric venous thrombosis. N Engl J Med. 2001;345:1683-1688.
93. Bilbao JI, Rodriguez-Cabello J, Longo J, et al. Portal thrombosis: percutaneous transhepatic treatment with urokinase - a case report. Gastrointest Radiol. 1989;14:326-329.
94. Karawi MA, Guaiz M, Clark D, et al. Mesenteric vein thrombosis, noninvasive diagnosis and follow up (US + MRI) and noninvasive therapy by streptokinase and anticoagulants. Hepatogastroenterology. 1990;37:507-509.
95. Rivitz SM, Geller SC, Hahn C, et al. Treatment of acute mesenteric venous thrombosis with transjugular intramesenteric urokinase infusion. J Vasc Intervent Radiol. 1995;6:219-223.
96. Train JS, Ross H, Weiss JD, et al. Mesenteric venous thrombosis: successful treatment by intraarterial lytic therapy. J Vasc Interv Radiol. 1998;9:461-464.
97. Ludwig DJ, Hauptmann E, Rosoff L Jr, Neuzil D. Mesenteric and portal vein thrombosis in a young patient with protein S deficiency treated with urokinase via the superior mesenteric artery. J Vasc Surg. 1999;30:551-554.
98. Poplausky MR, Kaufman JA, Geller SC, Waltman AC: Mesenteric venous thrombosis treated with urokinase via the superior mesenteric artery. Gastroenterol. 1996;110:1633-1635.
99. Sehgal M, Haskal ZJ: Use of transjugular intrahepatic portosystemic shunts during lytic therapy of extensive portal splenic and mesenteric venous thrombosis: long-term follow up. J Vasc Interv Radiol. 2000;11:61-65.
100. Lau LL, McMurray AH: Mesenteric venous thrombosis in protein S deficiency: case report and literature review. Ulster Med J. 1999;68:33-35.
101. Guglielmi A, Fior F, Halmos O, et al. Transhepatic fibrinolysis of mesenteric and portal vein thrombosis in a patient with ulcerative colitis: a case report. World J Gastroenterol. 2005;11:2035-2038.
102. Ozdogan M, Gurer A, Gokakin AK, et al. Thrombolysis via an operatively placed mesenteric catheter for portal and superior mesenteric vein thrombosis: report of a case. Surg Today. 2006;36:846-848.
103. Brunaud L, Antunes L, Collinet-Adler S, et al. Acute mesenteric venous thrombosis: case for nonoperative management. J Vasc Surg. 2001;34:673-679.
104. Morasch MD, Ebaugh JL, Chiou AC, et al. Mesenteric venous thrombosis: a changing clinical entity. J Vasc Surg. 2001;34:680-684.
105. Kim HS, Patra A, Khan J, et al. Transhepatic catheter-directed thrombectomy and thrombolysis of acute superior mesenteric venous thrombosis. J Vasc Intervent Radiol. 2005;16:1685-1691.
106. Takahashi N, Kuroki K, Yanaga K. Percutaneous transhepatic mechanical thrombectomy for acute mesenteric venous thrombosis. J Endovasc Therapy. 2005;12:508-511.
107. Rhee RY, Gloviczki P. Mesenteric vein thrombosis. Surg Clin North Am 1997;77:327-338.
108. Kaleya RN, Boley SJ. Mesenteric venous thrombosis. In: Najarian JS, Delaney JP, eds. Progress in Gastrointestinal Surgery. Chicago, IL: Yearbook Medical; 1989:417-425.
109. Frishman WH, Lerner RG, Klein MD, Roganovic M. Antiplatelet and antithrombotic drugs. In: Frishman WH, Sonnenblick EH, Sica DA, eds. Cardiovascular Pharmacotherapeutics. 2nd ed. New York, NY: McGraw Hill; 2003:259-299.
110. Cunningham CG, Reilly LM, Stoney R. Chronic visceral ischemia. Surg Clin North Am. 1992;72:231-244.
111. Rogers AI, David S. Intestinal blood flow and diseases of vascular impairment. In: Haubrich WS, Schaffner F, Berk JE, eds. Bockus: Gastroenterology. 5th ed. Philadelphia, PA: WB Saunders; 1995:1212-1234.
112. Schaefer PJ, Schaefer FK, Mueller-Huelsbeck S, Jahnke T. Chonic mesenteric ischemia: stenting of mesenteric arteries. Abdom Imaging. 2007;32:304-309.
113. Silva JA, White CJ, Collins TJ, et al. Endovascular therapy for chronic mesenteric ischemia. J Am Coll Cardiol. 2006;47:944-950.
114. Maspes F, Mazzetti G, Gandini R, et al. Percutaneous transluminal angioplasty in the treatment of chronic mesenteric ischemia: results and 3 years of follow-up in 23 patients. Abdom Imaging. 1998;23:358-363.
115. McShane MD, Proctor A, Spencer P, et al. Mesenteric angioplasty for chronic intestinal ischaemia. Eur J Vasc Surg. 1992;6:333-336.
116. Schaefer PJ, Schaefer FK, Hinrichsen H, et al. Stent placement with the monorail technique for treatment of mesenteric artery stenosis. J Vasc Intervent Radiol. 2006;17:637-643.
117. Sivamurthy N, Rhodes JM, Lee D, et al. Endovascular versus open mesenteric revascularization: Immediate benefits do not equate with short-term functional outcomes. J Am Coll Surg. 2006;202:859-867.
118. Mavrelis PG, Doumanian H: Pentoxifylline for mesenteric ischemia (letter). Am J Gastroenterol. 1987;82:175.
119. Hass DJ, Kozuch P, Brandt LJ: Pharmacologically-mediated colon ischemia. Am J Gastroenterol. 2007;102:1765-1780.
120. Anon R, Bosca MM, Sanchiz V, et al. Factors predicting poor prognosis in ischemic colitis. World J Gastroenterol. 2006;14:4875-4876.
121. Sarnoff SJ, Fine J. Effect of chemotherapy on ileum subjected to vascular injury. Ann Surg. 1945;121:74.
122. Poth EJ, McClure JN Jr. Intestinal obstruction: protective action of sulfasuxidine and sulfathalidine to ileum following vascular damage. Ann Surg. 1950;131:159-170.
123. Sotiriadis J, Khorshidi I, Brandt LJ. Does colon ischemia have a wose prognosis when isolated to the right side? Gastroenterology. 2006;130:T1037.
124. Sotiriadis J, Lee S, Brand LJ. Isolated right colon ischemia (IRCI) may be the heralding presentation of acute superior mesenteric artery (SMA) occlusion. Am J Gastroenterol. 2006;101:523.